Incident: The company signed a strategic cooperation agreement with Yinkang Shanghai) Health Development Co., Ltd. and Tianjin Advantage Venture Capital Management Co., Ltd. Comment: Firmly transform and upgrade, enter the healthcare field, and maintain an increase in holdings rating. After establishing a merger and acquisition fund with Shangxin Capital in June 2015, the company announced that it signed a strategic cooperation agreement with Yinkang (Shanghai) Health Development Co., Ltd. and Tianjin Advantage Venture Capital Management Co., Ltd., where the partners will formulate a merger, acquisition and restructuring strategy for the company in line with its capital and industrial development direction, seek high-quality medical industry targets, and provide post-investment collaborative management services, and jointly establish a medical industry merger and acquisition fund (with a provisional scale of 1.5 billion dollars) to help the company transform and upgrade. It can be seen that the company's determination to transform and upgrade into the healthcare field is firm. Maintain the profit forecast of 0.29/0.36/0.47 yuan EPS for 2015-17, considering that the company's future layout in the medical and health sector is expected to be further implemented, and maintain an increase in holdings rating. The partners are rich in investment, management and operation, helping the company to transform and upgrade. 1) Yinkang Health Development is a group company specializing in healthcare services, involving various segments such as medical devices, medical services, and trusteeship. The investment projects include affinity pension (which has been announced to have signed an acquisition agreement with Yihua Health), Lushan Health Care City, and Shenshan International Resort and Health City, with rich medical industry resources and management experience; 2) Tianjin's leading entrepreneurship is a professional organization engaged in strategic consulting, mergers and acquisitions, M&A consulting, and private equity investment. It has rich experience in mergers and acquisitions and extensive financial resources. Taking advantage of the partners' advantages in the field of medical mergers and acquisitions, in the future, the company will explore a number of mature, rapidly growing targets suitable for direct mergers and acquisitions by listed companies, which will help the company's industrial layout and smooth transformation in the two fields of healthcare and Internet upgrading. The main seamless clothing industry benefits from increased industry concentration and the release of production capacity, and is expected to improve revenue and profit levels in the next few years. 1) With the gradual clearing of the seamless clothing industry market and increasing concentration due to continuous upgrading of consumption, the company's seamless clothing domestic and global market shares are about 2.08% and 1.11%, and it is expected that the company will continue to benefit from the increase in industry concentration. 2) Upstream production capacity was increased by 150 million yuan in 2014 through allotment of shares. It is estimated that production capacity can be released in 2016. Costs are reduced through the extension of the industrial chain, and gross margin is expected to increase by about 3-5 pct. Risk warning: the risk of uncertainty in strategic agreements; the main clothing industry continues to decline;